Search results

This quality standard covers assessing if people need help with their medicines and deciding what medicines support is needed to enable people to manage their medicines. It also includes communication between health and social care staff, to ensure people have the medicines support they need. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

24 July 2018

Evidence-based recommendations on ivabradine (Procoralan) for treating chronic heart failure in adults.

Result type

Technology appraisal guidance

Published

28 November 2012

Evidence-based recommendations on sotagliflozin with insulin for treating type 1 diabetes in adults with a body mass index (BMI) of at least 27 kg/m2 , when insulin alone does not provide adequate glycaemic control despite optimal insulin therapy.

Result type

Technology appraisal guidance

Published

12 February 2020

Evidence-based recommendations on ixekizumab (Taltz) for moderate to severe plaque psoriasis in adults.

Result type

Technology appraisal guidance

Published

26 April 2017

Evidence-based recommendations on transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia in adults. This involves using heated water vapour to destroy some of the prostate tissue.

Result type

Interventional procedures guidance

Published

21 August 2018

Evidence-based recommendations on coil embolisation of unruptured intracranial aneurysms. This involves placing coils inside the aneurysm using a thin tube to make the blood clot so it is less likely to burst.

Result type

Interventional procedures guidance

Published

26 January 2005

Evidence-based recommendations on photodynamic therapy for brain tumours. This involves giving the patient a drug that makes the tissue sensitive to light and then activating it with a laser light source to destroy the tumour cells.

Result type

Interventional procedures guidance

Published

25 March 2009

Evidence-based recommendations on balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension in adults. This involves inserting and inflating a balloon in blocked blood vessels in the lungs to improve blood flow.

Result type

Interventional procedures guidance

Published

27 April 2016

Evidence-based recommendations on artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure. This involves replacing the 2 lower chambers of the heart with a mechanical device to improve circulation until heart transplantation.

Result type

Interventional procedures guidance

Published

20 December 2017

Evidence-based recommendations on Plus Sutures for preventing surgical site infection.

Result type

Medical technologies guidance

Published

28 June 2021

This guideline covers needle and syringe programmes for people (including those under 16) who inject drugs. The main aim is to reduce the transmission of viruses and other infections caused by sharing injecting equipment, such as HIV, hepatitis B and C. In turn, this will reduce the prevalence of blood-borne viruses and bacterial infections, so benefiting wider society.

Result type

Public health guideline

Published

26 March 2014

Evidence-based recommendations on benralizumab (Fasenra) for treating severe eosinophilic asthma in adults.

Result type

Technology appraisal guidance

Last updated

3 September 2019

Evidence-based recommendations on talazoparib (Talzenna) for HER2-negative, locally advanced or metastatic breast cancer with germline BRCA1 or BRCA2 mutations in adults.

Result type

Technology appraisal guidance

Published

21 February 2024

Evidence-based recommendations on laparoscopic repair of abdominal aortic aneurysm. This involves replacing the damaged parts of the aorta with an artificial piece of blood vessel, performed through small cuts in the abdomen (keyhole surgery).

Result type

Interventional procedures guidance

Published

22 August 2007

Evidence-based recommendations on ibrutinib (Imbruvica) with venetoclax (Venclyxto) for untreated chronic lymphocytic leukaemia in adults.

Result type

Technology appraisal guidance

Published

31 May 2023